Weigao Group buys back 1.67 million H-shares, treasury stock rises to 47.94 million

Bulletin Express03-31

Shandong Weigao Group Medical Polymer Company Limited (Weigao Group) filed a Next Day Disclosure Return showing that 1.67 million H-shares were repurchased on 31 March 2026 through the Hong Kong Stock Exchange at prices between HKD 3.73 and HKD 3.93, equal to a volume-weighted average of HKD 3.817 per share. The transaction cost totalled HKD 6.39 million and represented 0.0374% of the company’s issued share capital excluding treasury shares.

Following the repurchase, Weigao Group’s outstanding shares (excluding treasury) decreased to approximately 4.47 billion, while treasury shares increased to 47.94 million. Total issued shares remained unchanged at about 4.52 billion.

The buy-back formed part of the mandate approved on 27 May 2025, which permits the repurchase of up to 451.56 million shares. Cumulative repurchases under this mandate now stand at 41.30 million shares, equivalent to 9.15% of the share base at the mandate date. All shares bought back to date are held as treasury shares, and none have been cancelled. The company is subject to a moratorium on issuing new shares or disposing of treasury shares until 1 May 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1174674275?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-31 17:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1174674275","market":"hk","top_or_hot":-1,"title":"Weigao Group buys back 1.67 million H-shares, treasury stock rises to 47.94 million","media":"Bulletin Express","content":"<p>Shandong Weigao Group Medical Polymer Company Limited (Weigao Group) filed a Next Day Disclosure Return showing that 1.67 million H-shares were repurchased on 31 March 2026 through the Hong Kong Stock Exchange at prices between HKD 3.73 and HKD 3.93, equal to a volume-weighted average of HKD 3.817 per share. The transaction cost totalled HKD 6.39 million and represented 0.0374% of the company’s issued share capital excluding treasury shares.</p>\n<p>Following the repurchase, Weigao Group’s outstanding shares (excluding treasury) decreased to approximately 4.47 billion, while treasury shares increased to 47.94 million. Total issued shares remained unchanged at about 4.52 billion.</p>\n<p>The buy-back formed part of the mandate approved on 27 May 2025, which permits the repurchase of up to 451.56 million shares. Cumulative repurchases under this mandate now stand at 41.30 million shares, equivalent to 9.15% of the share base at the mandate date. All shares bought back to date are held as treasury shares, and none have been cancelled. The company is subject to a moratorium on issuing new shares or disposing of treasury shares until 1 May 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Weigao Group buys back 1.67 million H-shares, treasury stock rises to 47.94 million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWeigao Group buys back 1.67 million H-shares, treasury stock rises to 47.94 million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-31 17:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shandong Weigao Group Medical Polymer Company Limited (Weigao Group) filed a Next Day Disclosure Return showing that 1.67 million H-shares were repurchased on 31 March 2026 through the Hong Kong Stock Exchange at prices between HKD 3.73 and HKD 3.93, equal to a volume-weighted average of HKD 3.817 per share. The transaction cost totalled HKD 6.39 million and represented 0.0374% of the company’s issued share capital excluding treasury shares.</p>\n<p>Following the repurchase, Weigao Group’s outstanding shares (excluding treasury) decreased to approximately 4.47 billion, while treasury shares increased to 47.94 million. Total issued shares remained unchanged at about 4.52 billion.</p>\n<p>The buy-back formed part of the mandate approved on 27 May 2025, which permits the repurchase of up to 451.56 million shares. Cumulative repurchases under this mandate now stand at 41.30 million shares, equivalent to 9.15% of the share base at the mandate date. All shares bought back to date are held as treasury shares, and none have been cancelled. The company is subject to a moratorium on issuing new shares or disposing of treasury shares until 1 May 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01066","symbol_name":"威高股份","start_time":0,"source_url":"","article_id":"1174674275","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1174674275","pubTimestamp":1774950449,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shandong Weigao Group Medical Polymer Company Limited (Weigao Group) filed a Next Day Disclosure Return showing that 1.67 million H-shares were repurchased on 31 March 2026 through the Hong Kong...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01066":"威高股份"},"translate_title":"威高集团回购167万股H股库存股升至4794万股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01066":1},"content_text":"Shandong Weigao Group Medical Polymer Company Limited (Weigao Group) filed a Next Day Disclosure Return showing that 1.67 million H-shares were repurchased on 31 March 2026 through the Hong Kong Stock Exchange at prices between HKD 3.73 and HKD 3.93, equal to a volume-weighted average of HKD 3.817 per share. The transaction cost totalled HKD 6.39 million and represented 0.0374% of the company’s issued share capital excluding treasury shares.\nFollowing the repurchase, Weigao Group’s outstanding shares (excluding treasury) decreased to approximately 4.47 billion, while treasury shares increased to 47.94 million. Total issued shares remained unchanged at about 4.52 billion.\nThe buy-back formed part of the mandate approved on 27 May 2025, which permits the repurchase of up to 451.56 million shares. Cumulative repurchases under this mandate now stand at 41.30 million shares, equivalent to 9.15% of the share base at the mandate date. All shares bought back to date are held as treasury shares, and none have been cancelled. The company is subject to a moratorium on issuing new shares or disposing of treasury shares until 1 May 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1174674275","isCrawlerRequest":true}